Molecular signaling pathways in doxorubicin-induced nephrotoxicity and potential therapeutic agents
International Immunopharmacology · 2025-01 · 144 · 113373
DOI: 10.1016/j.intimp.2024.113373 ↗Kurz gefasst
Übersichtsarbeit in der Zeitschrift International Immunopharmacology, 2025-01. Verfasst von Changxu Lu und 5 weiteren Autor:innen. Beteiligte Einrichtung: College of Exercise and Health, Shenyang Sport University, Shenyang, Liaoning, China; Department of Urology, Liaoning Cancer Hospital & Institute, Ca…. Hauptthemen laut MEDLINE: Signal Transduction, Doxorubicin, Kidney Diseases. Die Arbeit wurde bisher 36-mal zitiert (Crossref) und nennt 261 Literaturangaben. Gefördert von: Department of Science and Technology of Liaoning Province, National Cancer Center, University of Science and Technology Liaoning.
Abstract (Originalsprache)
Doxorubicin (DOX), an anthracycline chemotherapeutic agent, is extensively utilized in the clinical management of both solid and hematological malignancies. Nevertheless, the clinical application of this treatment is significantly limited by adverse reactions and toxicity that may arise during or after administration. Its cytotoxic effects are multifaceted, with cardiotoxicity being the most prevalent side effect. Furthermore, it has the potential to adversely affect other organs, including the brain, kidneys, liver, and so on. Notably, it has been reported that DOX may cause renal failure in patients and there is currently no effective treatment for DOX-induced kidney damage, which has raised a high concern about DOX-induced nephrotoxicity (DIN). Although the precise molecular mechanisms underlying DIN remain incompletely elucidated, prior research has indicated that reactive oxygen species (ROS) are pivotal in this process, triggering a cascade of detrimental pathways including apoptosis, inflammation, dysregulated autophagic flux, and fibrosis. In light of these mechanisms, decades of research have uncovered several DIN-associated signaling pathways and found multiple potential therapeutic agents targeting them. Thus, this review intends to delineate the DIN associated signaling pathways, including AMPK, JAKs/STATs, TRPC6/RhoA/ROCK1, YAP/TEAD, SIRTs, Wnt/β-catenin, TGF-β/Smad, MAPK, Nrf2/ARE, NF-κB, and PI3K/AKT, and to summarize their potential regulatory agents, which provide a reference for the development of novel medicines against DIN.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- College of Exercise and Health, Shenyang Sport University, Shenyang, Liaoning, China; Department of Urology, Liaoning Cancer Hospital & Institute, Cancer Hospital of Dalian University of Technology, Cancer Hospital of C…
- College of Exercise and Health, Shenyang Sport University, Shenyang, Liaoning, China.
- College of Exercise and Health, Shenyang Sport University, Shenyang, Liaoning, China. Electronic address: sun18940103126@163.com.
- College of Basic Medical Science, China Medical University, Shenyang, Liaoning, China. Electronic address: ddong@cmu.edu.cn.
- Department of Urology, Liaoning Cancer Hospital & Institute, Cancer Hospital of Dalian University of Technology, Cancer Hospital of China Medical University, Shenyang, Liaoning, China. Electronic address: muzhongyi@163.…
Förderung
- Department of Science and Technology of Liaoning Province
- National Cancer Center
- University of Science and Technology Liaoning
- Department of Education of Liaoning Province
- Scientific Research Fund of Liaoning Provincial Education Department
Zitieren
APA
Lu, C., Wei, J., Gao, C., Sun, M., Dong, D., & Mu, Z. (2025). Molecular signaling pathways in doxorubicin-induced nephrotoxicity and potential therapeutic agents. International Immunopharmacology, 144, 113373. https://doi.org/10.1016/j.intimp.2024.113373
Vancouver
Lu C, Wei J, Gao C, Sun M, Dong D, Mu Z. Molecular signaling pathways in doxorubicin-induced nephrotoxicity and potential therapeutic agents. International Immunopharmacology. 2025;144:113373. doi:10.1016/j.intimp.2024.113373
BibTeX
@article{Lu2025,
author = {Lu, Changxu and Wei, Jinwen and Gao, Can and Sun, Mingli and Dong, Dan and Mu, Zhongyi},
title = {Molecular signaling pathways in doxorubicin-induced nephrotoxicity and potential therapeutic agents},
journal = {International Immunopharmacology},
year = {2025},
volume = {144},
pages = {113373},
doi = {10.1016/j.intimp.2024.113373}
}
EUVIMED